<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chung S</submitter><funding>Ministry of Science, ICT and Future Planning (MSIP)</funding><funding>Ministry of Health and Welfare (Ministry of Health, Welfare and Family Affairs)</funding><funding>Ministry of Education (Ministry of Education of the Republic of Korea)</funding><pagination>1936-1951</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11447230</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>56(9)</volume><pubmed_abstract>Abnormal glial activation promotes neurodegeneration in Alzheimer's disease (AD), the most common cause of dementia. Stimulation of the cGAS-STING pathway induces microglial dysfunction and sterile inflammation, which exacerbates AD. We showed that inhibiting STING activation can control microglia and ameliorate a wide spectrum of AD symptoms. The cGAS-STING pathway is required for the detection of ectopic DNA and the subsequent immune response. Amyloid-β (Aβ) and tau induce mitochondrial stress, which causes DNA to be released into the cytoplasm of microglia. cGAS and STING are highly expressed in Aβ plaque-associated microglia, and neuronal STING is upregulated in the brains of AD model animals. The presence of the APOE ε4 allele, an AD risk factor, also upregulated both proteins. STING </pubmed_abstract><journal>Experimental &amp; molecular medicine</journal><pubmed_title>Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer's disease pathologies.</pubmed_title><pmcid>PMC11447230</pmcid><funding_grant_id>2020R1A6A3A13070845</funding_grant_id><funding_grant_id>HU23C1234</funding_grant_id><pubmed_authors>Chung S</pubmed_authors><pubmed_authors>Jeong JH</pubmed_authors><pubmed_authors>Mook-Jung I</pubmed_authors><pubmed_authors>Kim JI</pubmed_authors><pubmed_authors>Lee Y</pubmed_authors><pubmed_authors>Han JW</pubmed_authors><pubmed_authors>Park JC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer's disease pathologies.</name><description>Abnormal glial activation promotes neurodegeneration in Alzheimer's disease (AD), the most common cause of dementia. Stimulation of the cGAS-STING pathway induces microglial dysfunction and sterile inflammation, which exacerbates AD. We showed that inhibiting STING activation can control microglia and ameliorate a wide spectrum of AD symptoms. The cGAS-STING pathway is required for the detection of ectopic DNA and the subsequent immune response. Amyloid-β (Aβ) and tau induce mitochondrial stress, which causes DNA to be released into the cytoplasm of microglia. cGAS and STING are highly expressed in Aβ plaque-associated microglia, and neuronal STING is upregulated in the brains of AD model animals. The presence of the APOE ε4 allele, an AD risk factor, also upregulated both proteins. STING </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Sep</publication><modification>2025-04-26T20:13:04.004Z</modification><creation>2025-04-06T16:25:38.756Z</creation></dates><accession>S-EPMC11447230</accession><cross_references><pubmed>39218977</pubmed><doi>10.1038/s12276-024-01295-y</doi></cross_references></HashMap>